Tilray Brands
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Tilray Brands and other ETFs, options, and stocks.About TLRY
Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness.
TLRY Key Statistics
Stock Snapshot
With a market cap of 1.29B, Tilray Brands(TLRY) trades at $11.14. The stock has a price-to-earnings ratio of -0.54.
On 2025-12-19, Tilray Brands(TLRY) stock moved within a range of $11.00 to $12.70. With shares now at $11.14, the stock is trading +1.3% above its intraday low and -12.3% below the session's peak.
Trading volume for Tilray Brands(TLRY) stock has reached 22.36M, versus its average volume of 30.54M.
The stock's 52-week range extends from a low of $3.51 to a high of $23.20.
The stock's 52-week range extends from a low of $3.51 to a high of $23.20.
TLRY News
Why did Tilray's 30% gain evaporate this week? It was an exciting week in the cannabis sector. Rumors that President Trump was planning to reclassify marijuana...
Tilray Brands (NASDAQ:TLRY), a global medical cannabis producer, closed Thursday at $12.34, down 4.2%. Tilray Brands IPO'd in 2018 and has fallen 94% since goin...
Tilray (TLRY) Medical, a division of Tilray Brands, confirmed its planned strategic framework to advance its U.S. medical cannabis operations following federal...
Analyst ratings
80%
of 10 ratingsMore TLRY News
Rescheduling would lift regulatory pressures that have been weighing on US cannabis operators' margins. Shares of weed companies, many of which don’t sell canna...
Shares of Tilray Brands (TLRY) moved back into positive territory after slipping earlier this week. The latest swings came after President Trump confirmed that...
Tilray Brands (NASDAQ:TLRY), global medical cannabis producer, closed Tuesday’s session at $13.94, up 27.54%. Trading volume reached 46.8 million shares, about...
Tilray Brands (TLRY) just rode a wave of optimism after reports that President Trump plans to reclassify marijuana to Schedule III, a potential game changer for...
Tilray Brands recently announced that its Redecan unit launched Amped Live Resin Liquid Diamond 1g 510 cartridges in Canada, while also promoting a broad 2025 h...
If you are wondering whether Tilray Brands is finally a smart buy or just another volatile cannabis story, you are not alone. That is exactly what we are going...
Tilray's stock, and shares of other cannabis companies, soared after reports gave investors hope that the Trump administration would move to have marijuana recl...
